Literature DB >> 21792753

Clinical trial design in the neurocritical care unit.

C E Hall1, M Mirski, Y Y Palesch, M N Diringer, A I Qureshi, C S Robertson, R Geocadin, C A C Wijman, P D Le Roux, Jose I Suarez.   

Abstract

Clinical trials provide a robust mechanism to advance science and change clinical practice across the widest possible spectrum. Fundamental in the Neurocritical Care Society's mission is to promote Quality Patient Care by identifying and implementing best medical practices for acute neurological disorders that are consistent with the current scientific knowledge. The next logical step will be to foster rapid growth of our scientific body of evidence, to establish and disseminate these best practices. In this manuscript, five invited experts were impaneled to address questions, identified by the conference organizing committee as fundamental issues for the design of clinical trials in the neurological intensive care unit setting.

Entities:  

Mesh:

Year:  2012        PMID: 21792753     DOI: 10.1007/s12028-011-9608-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  44 in total

1.  Power and sample size determination when assessing the clinical relevance of trial results by 'responder analyses'.

Authors:  Meinhard Kieser; Joachim Röhmel; Tim Friede
Journal:  Stat Med       Date:  2004-11-15       Impact factor: 2.373

Review 2.  Nonconventional clinical trial designs: approaches to provide more precise estimates of treatment effects with a smaller sample size, but at a cost.

Authors:  George Howard
Journal:  Stroke       Date:  2007-02       Impact factor: 7.914

3.  Using binary logistic regression models for ordinal data with non-proportional odds.

Authors:  R Bender; U Grouven
Journal:  J Clin Epidemiol       Date:  1998-10       Impact factor: 6.437

4.  Surrogate endpoints in clinical trials: definition and operational criteria.

Authors:  R L Prentice
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

5.  Community consultation in emergency research.

Authors:  Charles Contant; Laurence B McCullough; Lorna Mangus; Claudia Robertson; Alex Valadka; Baruch Brody
Journal:  Crit Care Med       Date:  2006-08       Impact factor: 7.598

6.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

7.  Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials.

Authors:  Jeffrey L Saver; Banafsheh Yafeh
Journal:  Stroke       Date:  2007-01-18       Impact factor: 7.914

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.

Authors:  Jeffrey L Saver
Journal:  Arch Neurol       Date:  2004-07

10.  Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics.

Authors:  Ewout W Steyerberg; Nino Mushkudiani; Pablo Perel; Isabella Butcher; Juan Lu; Gillian S McHugh; Gordon D Murray; Anthony Marmarou; Ian Roberts; J Dik F Habbema; Andrew I R Maas
Journal:  PLoS Med       Date:  2008-08-05       Impact factor: 11.069

View more
  3 in total

Review 1.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

2.  Quantification of errors in ordinal outcome scales using shannon entropy: effect on sample size calculations.

Authors:  Pitchaiah Mandava; Chase S Krumpelman; Jharna N Shah; Donna L White; Thomas A Kent
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

Review 3.  Functional Assessment for Acute Stroke Trials: Properties, Analysis, and Application.

Authors:  Martin Taylor-Rowan; Alastair Wilson; Jesse Dawson; Terence J Quinn
Journal:  Front Neurol       Date:  2018-03-26       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.